Search research articles
Contact Us
Filters
Showing results (81-90 of 167) with videos related to
Page
of 17
Sort By:
Journal of Infection and Public Health
|
November 12, 2013
Evaluation of the potential impact of a carbapenem de-escalation program in an academic healthcare system
Farah Ahmad, Jason M Pogue, Dror Marchaim, et al.
Antimicrobial Agents and Chemotherapy
|
November 1, 2017
Identification of Vancomycin Exposure-Toxicity Thresholds in Hospitalized Patients Receiving Intravenous Vancomycin
Evan J Zasowski, Kyle P Murray, Trang D Trinh, et al.
Open Forum Infectious Diseases
|
July 16, 2020
Old In Vitro Antimicrobial Breakpoints Are Misleading Stewardship Efforts, Delaying Adoption of Innovative Therapies, and Harming Patients
Paul G Ambrose, Sujata M Bhavnani, David R Andes, et al.
Open Forum Infectious Diseases
|
June 6, 2020
The Impact of Multidrug-Resistant Organisms on Outcomes in Patients With Diabetic Foot Infections
Oryan Henig, Jason M Pogue, Emily Martin, et al.
Infectious Diseases and Therapy
|
October 23, 2019
Relationship Status between Vancomycin Loading Dose and Treatment Failure in Patients with MRSA Bacteremia: It's Complicated
Jessica K Ortwine, Evan J Zasowski, Jason M Pogue, et al.
Pharmacotherapy
|
September 20, 2011
Validation of the effectiveness of a vancomycin nomogram in achieving target trough concentrations of 15-20 mg/L suggested by the vancomycin consensus guidelines
Ravina Kullar, Steven N Leonard, Susan L Davis, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 18, 2025
First report of treatment-emergent resistance to cefepime-zidebactam in Pseudomonas aeruginosa
Ava J Dorazio, Samuel L Aitken, Virginia M Pierce, et al.
Antimicrobial Agents and Chemotherapy
|
April 26, 2017
Critical Need for Clarity in Polymyxin B Dosing
Nikolas J Onufrak, Gauri G Rao, Alan Forrest, et al.
The Journal of Antimicrobial Chemotherapy
|
September 7, 2018
Averting the post-antibiotic era: successful use of meropenem/vaborbactam for carbapenem-resistant Serratia marcescens and Enterobacter aerogenes bacteraemia in a haemodialysis patient
Sarah C J Jorgensen, Philip McDonald, Ryan P Mynatt, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
July 24, 2012
Growing prevalence of Providencia stuartii associated with the increased usage of colistin at a tertiary health care center
Kayoko Hayakawa, Dror Marchaim, George W Divine, et al.
Page
of 17
Search research articles
Search
Showing results (81-90 of 167) with videos related to
Sort By:
Page
of 17
Journal of Infection and Public Health
|
November 12, 2013
Evaluation of the potential impact of a carbapenem de-escalation program in an academic healthcare system
Farah Ahmad, Jason M Pogue, Dror Marchaim, et al.
Antimicrobial Agents and Chemotherapy
|
November 1, 2017
Identification of Vancomycin Exposure-Toxicity Thresholds in Hospitalized Patients Receiving Intravenous Vancomycin
Evan J Zasowski, Kyle P Murray, Trang D Trinh, et al.
Open Forum Infectious Diseases
|
July 16, 2020
Old In Vitro Antimicrobial Breakpoints Are Misleading Stewardship Efforts, Delaying Adoption of Innovative Therapies, and Harming Patients
Paul G Ambrose, Sujata M Bhavnani, David R Andes, et al.
Open Forum Infectious Diseases
|
June 6, 2020
The Impact of Multidrug-Resistant Organisms on Outcomes in Patients With Diabetic Foot Infections
Oryan Henig, Jason M Pogue, Emily Martin, et al.
Infectious Diseases and Therapy
|
October 23, 2019
Relationship Status between Vancomycin Loading Dose and Treatment Failure in Patients with MRSA Bacteremia: It's Complicated
Jessica K Ortwine, Evan J Zasowski, Jason M Pogue, et al.
Pharmacotherapy
|
September 20, 2011
Validation of the effectiveness of a vancomycin nomogram in achieving target trough concentrations of 15-20 mg/L suggested by the vancomycin consensus guidelines
Ravina Kullar, Steven N Leonard, Susan L Davis, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 18, 2025
First report of treatment-emergent resistance to cefepime-zidebactam in Pseudomonas aeruginosa
Ava J Dorazio, Samuel L Aitken, Virginia M Pierce, et al.
Antimicrobial Agents and Chemotherapy
|
April 26, 2017
Critical Need for Clarity in Polymyxin B Dosing
Nikolas J Onufrak, Gauri G Rao, Alan Forrest, et al.
The Journal of Antimicrobial Chemotherapy
|
September 7, 2018
Averting the post-antibiotic era: successful use of meropenem/vaborbactam for carbapenem-resistant Serratia marcescens and Enterobacter aerogenes bacteraemia in a haemodialysis patient
Sarah C J Jorgensen, Philip McDonald, Ryan P Mynatt, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
July 24, 2012
Growing prevalence of Providencia stuartii associated with the increased usage of colistin at a tertiary health care center
Kayoko Hayakawa, Dror Marchaim, George W Divine, et al.
Page
of 17